CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 35,909 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Director acquired 47,403 shares (grant or award)
- 4 Grant or award Director acquired 30,909 shares (grant or award)
- 4 Grant or award Director acquired 31,818 shares (grant or award)
- 4 Grant or award Director acquired 49,545 shares (grant or award)
- 4 Open-market buy 10% owner bought 1,493 shares at $1.60 ($2,389)
- 4 Open-market buy 10% owner bought 2,450 shares at an average $1.59 ($3,903)
- 4 Open-market buy 10% owner bought 3,700 shares at an average $1.57 ($5,805)
- 4 Open-market buy 10% owner bought 30,700 shares at an average $1.46 ($44,748)
- 4 Open-market buy 10% owner bought 66,149 shares at an average $1.46 ($96,840)
- 4 Open-market buy 10% owner bought 255,100 shares at $1.96 ($499,996)
- 4 Open-market buy 10% owner bought 765,308 shares at $1.96 ($1,500,004)
- 4 Open-market buy 10% owner bought 512,043 shares at an average $1.96 ($1,003,504)
- 4 Grant or award Director acquired 27,711 shares (grant or award)
- 4 Grant or award Director acquired 36,082 shares (grant or award)
- 4 Grant or award Director acquired 26,340 shares (grant or award)
- 4 Grant or award Director acquired 28,091 shares (grant or award)
Page 15 of 28 · 551 filings